Raptamer Therapeutics
PrivateLast Round
Grant
Aug 11, 2021
Total Funding Raised
$3.72M
Company Overview
Raptamer Therapeutics is a biotechnology company that specializes in the development of next-generation, high-quality DNA molecules, called Raptamers, for use as therapeutic, diagnostic, or research agents.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raptamer Therapeutics Comparables
Compare Raptamer Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Base Pair Biotechnologies | 86% | |
| Aptagen, LLC | 84% | |
| TAGCyx Biotechnologies Inc. | 83% | |
Raptamer Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 11, 2021 | ||||
| Grant | Jun 1, 2011 |
Raptamer Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fannin Innovation Studio | M&A |
| Bill & Melinda Gates Foundation | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2021
$2M grant received from the National Institutes of Health.
- Jun 1, 2011
Received $1.7M from the Bill & Melinda Gates Foundation.
Raptamer Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Raptamer Therapeutics's valuation, stock price, and market status.